Aliases & Classifications for Cellulitis

Summaries for Cellulitis

MedlinePlus : 43 Cellulitis is an infection of the skin and deep underlying tissues. Group A strep (streptococcal) bacteria are the most common cause. The bacteria enter your body when you get an injury such as a bruise, burn, surgical cut, or wound. Symptoms include Fever and chills Swollen glands or lymph nodes A rash with painful, red, tender skin. The skin may blister and scab over. Your health care provider may take a sample or culture from your skin or do a blood test to identify the bacteria causing infection. Treatment is with antibiotics. They may be oral in mild cases, or intravenous (by IV) for more severe cases. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Cellulitis is related to wells syndrome and lymphedema, hereditary, ii, and has symptoms including exanthema, fever and pruritus. An important gene associated with Cellulitis is IL5 (Interleukin 5), and among its related pathways/superpathways are Bacterial infections in CF airways and Hematopoietic cell lineage. The drugs Clindamycin and Lincomycin have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and testes, and related phenotype is immune system.

Disease Ontology : 12 A skin disease where there is a diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by exogenous bacteria, and often occurs where the skin has previously been broken

Wikipedia : 76 Cellulitis is a bacterial infection involving the inner layers of the skin. It specifically affects the... more...

Related Diseases for Cellulitis

Diseases related to Cellulitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 386)
# Related Disease Score Top Affiliating Genes
1 wells syndrome 32.5 CRP IL1R1 IL5 RNASE3
2 lymphedema, hereditary, ii 31.5 CAMP GJC2
3 sinusitis 31.0 DEFB4A IL5 RNASE3
4 scleritis 30.7 IL5 TNF
5 folliculitis 30.4 DEFB4A IL5
6 churg-strauss syndrome 29.9 IL5 RNASE3 TNF
7 keratoconjunctivitis 29.9 IL5 RNASE3 TNF
8 diverticulitis 29.7 CRP TNF
9 meningitis 29.6 CRP LACTB TNF
10 pneumonia 29.5 CRP IL5 LACTB TNF
11 endocarditis 29.5 CRP LACTB TNF
12 spondylitis 29.4 CHI3L1 CRP TNF
13 pyomyositis 29.4 CRP SUCLG2
14 skin disease 29.2 CAMP DEFB4A IL5 TNF
15 rheumatoid arthritis 28.8 CHI3L1 CRP IL1R1 TNF
16 orbital cellulitis 12.4
17 perifolliculitis capitis abscedens et suffodiens, familial 12.0
18 tinea unguium 11.3
19 erysipelas 11.2
20 parametritis 11.2
21 ludwig's angina 11.2
22 lacrimal duct defect 11.1
23 erysipeloid 11.1
24 nocardiosis 11.1
25 vulvar vestibulitis syndrome 10.8 IL1R1 TNF
26 angioimmunoblastic lymphadenopathy with dysproteinemia 10.8 IL5 TNF
27 lymphedema, hereditary, ia 10.8
28 whim syndrome 10.8
29 fusariosis 10.8
30 clear cell acanthoma 10.8
31 elizabethkingia anophelis infection 10.8
32 loeffler endocarditis 10.8 IL5 RNASE3
33 cold urticaria 10.8 IL1R1 RNASE3
34 cardiac sarcoidosis 10.8 IL5 TNF
35 cough variant asthma 10.8 IL5 RNASE3
36 inflammatory bowel disease 4 10.8 IL5 RNASE3
37 cow milk allergy 10.8 IL5 RNASE3
38 paragonimiasis 10.8 IL5 RNASE3
39 intrinsic asthma 10.8 IL5 RNASE3
40 atopic keratoconjunctivitis 10.8 IL5 RNASE3
41 eosinophilic gastroenteritis 10.8 IL5 RNASE3
42 chronic eosinophilic pneumonia 10.8 IL5 RNASE3
43 latex allergy 10.7 IL5 RNASE3
44 gastrointestinal allergy 10.7 IL5 RNASE3
45 urinary schistosomiasis 10.7 IL5 RNASE3
46 chronic conjunctivitis 10.7 IL5 RNASE3
47 status asthmaticus 10.7 IL5 RNASE3
48 kimura disease 10.7 IL5 RNASE3
49 vernal keratoconjunctivitis 10.7 IL5 RNASE3
50 post-transplant lymphoproliferative disease 10.6 IL1R1 TNF

Graphical network of the top 20 diseases related to Cellulitis:



Diseases related to Cellulitis

Symptoms & Phenotypes for Cellulitis

UMLS symptoms related to Cellulitis:


exanthema, fever, pruritus

MGI Mouse Phenotypes related to Cellulitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.23 CAMP CHI3L1 CRP FLT4 GJC2 IL1R1

Drugs & Therapeutics for Cellulitis

Drugs for Cellulitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 213)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 18323-44-9 29029
2
Lincomycin Approved, Vet_approved Phase 4 154-21-2 656509
3
Cefazolin Approved Phase 4,Phase 3,Phase 2,Not Applicable 25953-19-9 656510 33255
4
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
5
Daptomycin Approved, Investigational Phase 4,Phase 2 103060-53-3 16129629
6
Vancomycin Approved Phase 4,Phase 3,Phase 2 1404-90-6 441141 14969
7
Oxacillin Approved, Investigational Phase 4,Phase 2 66-79-5 6196
8
Conivaptan Approved, Investigational Phase 4 210101-16-9 151171
9 Fondaparinux Approved, Investigational Phase 4 104993-28-4
10
Thrombin Approved, Investigational Phase 4
11
Dalbavancin Approved, Investigational Phase 4,Phase 3 91097-81-3, 171500-79-1 122186
12
Nafcillin Approved, Investigational Phase 4,Phase 2 985-16-0, 147-52-4 8982
13
Teicoplanin Approved, Investigational Phase 4,Phase 3 61036-62-2
14
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
15
Lenograstim Approved, Investigational Phase 4 135968-09-1
16
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
17
Amoxicillin Approved, Vet_approved Phase 4,Not Applicable 26787-78-0 33613
18
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
19 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
21 Clindamycin palmitate Phase 4,Phase 2,Phase 3,Not Applicable
22 Clindamycin phosphate Phase 4,Phase 2,Phase 3,Not Applicable
23 Floxacillin Phase 4,Not Applicable
24 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Not Applicable
25 penicillins Phase 4,Phase 2
26 Arginine Vasopressin Phase 4
27 Coagulants Phase 4,Not Applicable
28 Hemostatics Phase 4,Not Applicable
29 Natriuretic Agents Phase 4,Phase 3
30 Vasoconstrictor Agents Phase 4,Phase 3,Not Applicable
31 Vasopressins Phase 4
32 acivicin Phase 4
33 Hormones Phase 4,Phase 1,Phase 2,Not Applicable
34 Anticoagulants Phase 4
35 Antithrombin III Phase 4
36 Antithrombins Phase 4
37 Factor Xa Inhibitors Phase 4
38 Fibrinolytic Agents Phase 4
39 HIV Protease Inhibitors Phase 4,Phase 3,Not Applicable
40 PENTA Phase 4
41
protease inhibitors Phase 4,Phase 3,Not Applicable
42 Serine Proteinase Inhibitors Phase 4
43 Adjuvants, Immunologic Phase 4,Not Applicable
44 Antiviral Agents Phase 4,Not Applicable
45 Respiratory System Agents Phase 4,Not Applicable
46 Antitubercular Agents Phase 4,Phase 3,Not Applicable
47 methicillin Phase 4,Phase 2,Phase 3,Not Applicable
48 Antidotes Phase 4
49 Antioxidants Phase 4
50 diuretics Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 189)
# Name Status NCT ID Phase Drugs
1 Adjunctive Clindamycin for Cellulitis: C4C Trial. Unknown status NCT01876628 Phase 4 Flucloxacillin and Clindamycin;Flucloxacillin and placebo
2 RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Completed NCT00552799 Phase 4 Penicillin VK
3 Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Completed NCT00295178 Phase 4 Daptomycin;Vancomycin
4 The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Completed NCT01626560 Phase 4 Daptomycin;Vancomycin
5 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed NCT01549613 Phase 4 Daptomycin;Vancomycin
6 Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial Completed NCT00799292 Phase 4 Vasopressin
7 Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions Completed NCT02137447 Phase 4
8 A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia Completed NCT00435591 Phase 4 Conivaptan;placebo
9 The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty Completed NCT00909064 Phase 4 Fondaparinux Sodium (Arixtra)
10 Study of Wound Packing After Superficial Skin Abscess Drainage Completed NCT00746109 Phase 4
11 Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty Completed NCT01410240 Phase 4 FLOSEAL Hemostatic Matrix + Standard of care
12 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4 standard medical therapy;G-CSF;n-Acetylcysteine
13 Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Recruiting NCT03426761 Phase 4 Dalbavancin;Vancomycin
14 Group A Pharyngitis in Children: The GASPARD Study Recruiting NCT03264911 Phase 4 Amoxicillin or Placebo
15 World-wide Randomized Antibiotic Envelope Infection Prevention Trial Active, not recruiting NCT02277990 Phase 4
16 Penicillin for the Emergency Department Outpatient Treatment of CELLulitis Not yet recruiting NCT02922686 Phase 4 Flucloxacillin;Phenoxymethylpenicillin;Placebo (for phenoxymethylpenicillin)
17 Duration of ANtibiotic Therapy for CEllulitis Terminated NCT02032654 Phase 4 Flucloxacillin;Placebo (for flucloxacillin)
18 Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Terminated NCT00463801 Phase 4 Daptomycin
19 Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section Terminated NCT01528696 Phase 4
20 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
21 Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department Unknown status NCT00323219 Phase 3 Cefazolin and Moxifloxacin
22 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin Completed NCT00257036 Phase 2, Phase 3 levofloxacin
23 Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses Completed NCT01085929 Phase 3
24 Complicated Skin and Skin Structure Infections Completed NCT00619710 Phase 3 Meropenem;Imipenem-cilastatin
25 Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Completed NCT00729937 Phase 2, Phase 3 Cephalexin;Clindamycin;Trimethoprim-sulfamethoxazole
26 Evaluation of the Activity of a Pharmacological "Anticellulitis" Product vs. a Reference Product on the Market Completed NCT02195297 Phase 3
27 Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT02127970 Phase 3 Single Dose Dalbavancin;Two Dose Dalbavancin
28 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01431339 Phase 3 IV Dalbavancin;Vancomycin/Linezolid
29 Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed NCT01339091 Phase 3 Dalbavancin;Vancomycin / Linezolid
30 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252732 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
31 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252719 Phase 3 Single-Dose IV Oritavancin Diphosphate;IV Vancomycin
32 Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis Completed NCT00523341 Phase 3
33 Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses Completed NCT00973765 Phase 3 bactrim;placebo
34 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age Completed NCT02545543 Phase 3
35 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01576367 Phase 3
36 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT01302860 Phase 3 ACZ885
37 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Completed NCT00991146 Phase 3 canakinumab
38 Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Completed NCT00685373 Phase 3 Canakinumab (ACZ885)
39 Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome Completed NCT00465985 Phase 3 ACZ885;Placebo
40 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Completed NCT01499277 Phase 3 Ceftaroline fosamil;Vancomycin;Aztreonam
41 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00424190 Phase 3 IV Vancomycin plus IV Aztreonam;Ceftaroline
42 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00423657 Phase 3 ceftaroline;vancomycin plus aztreonam;Placebo
43 A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. Completed NCT02214225 Phase 3
44 A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. Completed NCT02914275 Phase 3
45 Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Completed NCT02066402 Phase 3 Tedizolid (BAY119-2631);Placebo Tedizolid (BAY119-2631);Linezolid;Placebo Linezolid
46 A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants Completed NCT01941940 Phase 3 Tocilizumab;DMARDs
47 Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination Recruiting NCT03131843 Phase 3 Alcohol;No alcohol
48 Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial Recruiting NCT02473341 Phase 3 Bovine Colostrum;Placebo
49 The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. Not yet recruiting NCT03556917 Phase 2, Phase 3
50 Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) Terminated NCT00865280 Phase 3 PTK 0796;linezolid

Search NIH Clinical Center for Cellulitis

Cochrane evidence based reviews: cellulitis

Genetic Tests for Cellulitis

Genetic tests related to Cellulitis:

# Genetic test Affiliating Genes
1 Cellulitis 29

Anatomical Context for Cellulitis

MalaCards organs/tissues related to Cellulitis:

41
Skin, Breast, Testes, Lymph Node, Colon, Kidney, T Cells

Publications for Cellulitis

Articles related to Cellulitis:

(show top 50) (show all 1192)
# Title Authors Year
1
Systemic corticosteroids may be beneficial for managing severe or refractory orbital cellulitis in children. ( 29920768 )
2018
2
Non-invasive assessment of cellulitis from snapshot hyperspectral imaging - A primary study. ( 29368433 )
2018
3
Indicators for imaging in periorbital cellulitis secondary to rhinosinusitis. ( 29450710 )
2018
4
Management of pediatric orbital cellulitis: A systematic review. ( 29859573 )
2018
5
Cellulitis: what to measure, how to define? Systematic review of outcomes from cellulitis trials. ( 29785809 )
2018
6
Tinea capitis mimicking dissecting cellulitis in three children. ( 29265536 )
2018
7
Clinical characteristics affecting length of stay in patients with cellulitis. ( 29415341 )
2018
8
Orbital Cellulitis ( 29939678 )
2018
9
A case report of orbital Langerhans cell histiocytosis presenting as a orbital cellulitis. ( 29643005 )
2018
10
Orbital cellulitis secondary to a fungal sinusitis caused by Scopulariopsis: The first case in Tunisia. ( 29709267 )
2018
11
Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. ( 29128228 )
2018
12
Non-tender recurrent scrotal cellulitis. ( 29440333 )
2018
13
Orbital Cellulitis-When Computed Tomography Imaging Is Falsely Reassuring. ( 29768298 )
2018
14
Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis. ( 29372251 )
2018
15
Seasonality of cellulitis: evidence from Google Trends. ( 29765240 )
2018
16
Patient factors associated with nationwide emergency department utilization for cellulitis. ( 29958742 )
2018
17
Group B Streptococcal Cellulitis and Necrotizing Fasciitis in Infants: A Systematic Review. ( 29424798 )
2018
18
Recurrent Cellulitis in a Patient with Papillomatosis Cutis Lymphostatica. ( 29849304 )
2018
19
Langerhans cell histiocytosis in an 18-month-old child presenting as periorbital cellulitis. ( 29755272 )
2018
20
Cellulitis and Bacteremia due to <i>Neisseria weaveri</i> following a dog bite. ( 29942750 )
2018
21
Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. ( 29428738 )
2018
22
Wells syndrome (eosinophilic cellulitis) caused by adrenal insufficiency and relieved by cortisone supplementation. ( 29398098 )
2018
23
Dissecting Cellulitis of the Scalp: A Rare Dermatological Manifestation of Crohn's Disease. ( 29430467 )
2018
24
Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient - a case report. ( 29374464 )
2018
25
The epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. ( 29427799 )
2018
26
Incidence of Cellulitis among Children with Primary Lymphedema. ( 29791815 )
2018
27
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom. ( 29867431 )
2018
28
Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole. ( 29522137 )
2018
29
Cellulitis caused by the Burkholderia cepacia complex associated with contaminated chlorhexidine 2% scrub in five domestic cats. ( 29877147 )
2018
30
Nasal septal abscess as a sequela of orbital cellulitis: An uncommon presentation. ( 29899988 )
2018
31
Fifteen-minute consultation: Preseptal and orbital cellulitis. ( 29934359 )
2018
32
Treatment of a Klebsiella pneumoniae KPC cellulitis and gut decolonization with ceftazidime/avibactam in a migrant from Libya. ( 29336224 )
2018
33
Orbital Cellulitis from an Orbital Compressed Air and Diesel Explosion Injury. ( 29611376 )
2018
34
Eosinophilic infiltrate resembling eosinophilic cellulitis (Wells syndrome) in a patient with mycosis fungoides. ( 29469767 )
2018
35
Clostridium perfringens panophthalmitis and orbital cellulitis: a case report. ( 29631556 )
2018
36
Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. ( 29427797 )
2018
37
Orbital apex syndrome from bacterial sinusitis without orbital cellulitis. ( 29468204 )
2018
38
<i>Shewanella</i> cellulitis and bacteremia following marine water exposure. ( 29942773 )
2018
39
Scleredema Diabeticorum with Superimposed Cellulitis and Abscess Formation. ( 29850291 )
2018
40
Ulcerative cellulitis of the arm: a case of primary cutaneous cryptococcosis. ( 29630156 )
2018
41
Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab. ( 29892672 )
2018
42
Trigeminal Trophic Syndrome Leading to Orbital Cellulitis. ( 29849238 )
2018
43
Erratum: Extranodal natural killer/T cell lymphoma, nasal type presenting as recurrent facial cellulitis. ( 29451197 )
2018
44
Hospital cost analysis of children with preseptal cellulitis. ( 29447901 )
2018
45
Variation in Care and Clinical Outcomes in Children Hospitalized With Orbital Cellulitis. ( 29208694 )
2018
46
Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis. ( 29900086 )
2018
47
Cellulitis and Soft Tissue Infections. ( 29404597 )
2018
48
An Unusual Case of Acute Chondrocalcinosis in Wrist Joint Presenting as Cellulitis. ( 29441250 )
2017
49
Orbital cellulitis and brain abscess - rare complications of maxillo-spheno-ethmoidal rhinosinusitis. ( 29450387 )
2017
50
Orbital Cellulitis Following Orbital Blow-out Fracture. ( 28806382 )
2017

Variations for Cellulitis

Expression for Cellulitis

Search GEO for disease gene expression data for Cellulitis.

Pathways for Cellulitis

GO Terms for Cellulitis

Cellular components related to Cellulitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 CAMP CHI3L1 CRP DEFB4A IL5 RNASE3
2 extracellular region GO:0005576 9.28 CAMP CHI3L1 CRP DEFB4A FLT4 IL1R1

Biological processes related to Cellulitis according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.81 DEFB4A IL1R1 IL5 TNF
2 inflammatory response GO:0006954 9.76 CHI3L1 CRP IL5 TNF
3 defense response GO:0006952 9.65 CAMP DEFB4A TNF
4 defense response to bacterium GO:0042742 9.56 CAMP DEFB4A RNASE3 TNF
5 defense response to Gram-negative bacterium GO:0050829 9.54 CAMP DEFB4A RNASE3
6 response to interleukin-1 GO:0070555 9.52 CHI3L1 IL1R1
7 innate immune response in mucosa GO:0002227 9.49 CAMP RNASE3
8 negative regulation of growth of symbiont in host GO:0044130 9.43 CAMP TNF
9 positive regulation of podosome assembly GO:0071803 9.4 IL5 TNF
10 antimicrobial humoral response GO:0019730 9.33 CAMP DEFB4A RNASE3
11 negative regulation of lipid storage GO:0010888 9.32 CRP TNF
12 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.13 CAMP DEFB4A RNASE3
13 defense response to Gram-positive bacterium GO:0050830 9.02 CAMP CRP DEFB4A RNASE3 TNF

Sources for Cellulitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....